A recent review article published in the British Journal of Clinical Pharmacology highlights that commonly available non-prescription CBD products, despite their widespread sale, have been found to be administered at doses that do not provide sufficient exposure to elicit a positive biological effect. The study indicated that the products evaluated did not meet the required levels for effectiveness, raising concerns about their potential impact. The findings underscore the importance of ensuring appropriate dosing when utilizing CBD products, as inadequate exposure levels can diminish any potential benefits. This informative research sheds light on the need for consumers to carefully consider the dosage and quality of CBD products they choose to use.